Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105087744A details DKR method for high-purity S-5-methyl-1-amino indan. Offers cost reduction in pharma manufacturing and supply chain reliability.
Discover the novel chemical resolution method for c-Met inhibitor PF-2341066. This patent analysis highlights cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel biocatalytic route for l-menthol using Bacillus subtilis ECU0554. High substrate tolerance up to 500mM and >96% ee. Ideal for flavor and pharma intermediates.
Advanced enzymatic resolution synthesis for chiral antifungal intermediates. Cost-effective, scalable production of high-purity pharmaceutical ingredients with superior stereocontrol.
Patent CN106397391A reveals efficient DKR synthesis for chiral alcohols offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105712889B reveals a cost-effective route for Ticagrelor intermediates. Discover kinetic resolution benefits and supply chain advantages for pharmaceutical manufacturing.
Patent CN112279765B details a novel NHC-catalyzed kinetic resolution for chiral alpha-fluoroketones, offering mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Patent CN101538542B reveals a novel Pseudomonas esterase for high-purity mandelic acid. This biocatalytic route offers significant cost reduction and supply chain reliability for chiral intermediates.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Novel enzymatic resolution process ensures greater than 99 percent ee value. Cost-effective Raney nickel catalyst reduces manufacturing expenses for reliable supply chain partners.
Patent CN117106845A reveals enzymatic resolution for chiral pyridine diols. This method offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing supply chains.
Patent CN114214375A details a novel enzymatic route for high-purity Ruxolitinib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107827890A reveals dynamic kinetic resolution for high-purity chiral purine acyclic nucleosides offering supply chain reliability and cost reduction.
Advanced patent CN104151352A details high-purity Sofosbuvir intermediate preparation via dynamic kinetic resolution ensuring supply chain reliability and cost efficiency.
Patent CN111194304B details an enzymatic method for chiral bridged rings. Offers high ee values and cost-effective manufacturing for pharmaceutical intermediates.
Novel patent CN102858759B enables high-purity Nebivolol production without HPLC, offering significant supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN103228640B details enzymatic resolution for nebivolol. This reduces waste and avoids HPLC, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110358804B reveals high-purity enzymatic resolution for dolutegravir synthesis, offering scalable biocatalysis solutions for reliable pharmaceutical intermediate suppliers.
Patent CN110577974B reveals a green enzymatic route for high-purity chiral tetrahydropyridines, offering significant cost reduction and scalability for pharmaceutical manufacturing.